High-quality data is the bedrock of an effective anti-money laundering (AML) and watchlist screening programme. Incomplete or inaccurate data can lead to false negatives, potentially allowing illicit ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DataVisor, the world's leading AI-powered fraud and financial crime prevention platform, is excited to announce significant enhancements to its advanced ...

Increasing geopolitical instability, regulatory developments, and technological advances are set to contribute to a rapidly changing anti-money laundering (AML) landscape in 2024. Here, we look at ...

Primary endpoint of pivotal phase 2 study met with statistical significance in using Revumenib for the treatment of relapsed/refractory mNPM1 AML patients; sNDA expected 1st half 2025. PDUFA action ...

Beyond the generally dismal trend in biotechs there are certainly some GlycoMimetics specifics that have led to its current low price. One is that its prior drug that completed Phase 3 trials, which ...